Frustaci, A. M., Tedeschi, A., Picardi, P., Mazzucchelli, M., Cairoli, R., & Montillo, M. (2016). Ofatumumab plus chlorambucil as a first-line therapy in less fit patients with chronic lymphocytic leukemia: Analysis of COMPLEMENT1 and other monoclonal antibodies association data. Ther Adv Hematol.

Frustaci, Anna Maria, Alessandra Tedeschi, Paola Picardi, Maddalena Mazzucchelli, Roberto Cairoli, and Marco Montillo. "Ofatumumab Plus Chlorambucil As a First-line Therapy in Less Fit Patients With Chronic Lymphocytic Leukemia: Analysis of COMPLEMENT1 and Other Monoclonal Antibodies Association Data." Ther Adv Hematol 2016.

Frustaci, Anna Maria, et al. "Ofatumumab Plus Chlorambucil As a First-line Therapy in Less Fit Patients With Chronic Lymphocytic Leukemia: Analysis of COMPLEMENT1 and Other Monoclonal Antibodies Association Data." Ther Adv Hematol 2016.